Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Sienna Biopharmaceuticals Inc. (SNNA)

0.19   0.007 (3.77%) 11-19 12:23
Open: 0.175 Pre. Close: 0.1831
High: 0.285 Low: 0.175
Volume: 3,520,746 Market Cap: 6M
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.2 - 0.201 0.201 - 0.202
Low: 0.167 - 0.169 0.169 - 0.17
Close: 0.178 - 0.18 0.18 - 0.182

Technical analysis

as of: 2019-11-19 12:01:32 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.38     One year: 0.51
Support: Support1: 0.15    Support2: 0.12
Resistance: Resistance1: 0.33    Resistance2: 0.44
Pivot: 0.18
Moving Average: MA(5): 0.20     MA(20): 0.18
MA(100): 0.51     MA(250): 1.83
MACD: MACD(12,26): -0.02     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 15.69     %D(3): 22.25
RSI: RSI(14): 47.28
52-week: High: 10.78  Low: 0.10  Change(%): -98.0
Average Vol(K): 3-Month: 528466  10-Days: 536124

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SNNA has closed below upper band by 40.6%. Bollinger Bands are 67.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to SNNA's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sienna Biopharma, unsecured creditors reach deal on executive bonuses
Sienna Biopharmaceuticals Inc won court approval on Tuesday for a deal with its unsecured creditors in which they will support planned executive bonuses in exchange for a recovery from the bankrupt clinical-stage developer of skin treatments.

Sienna Biopharmaceuticals Files for Bankruptcy
The move to seek protection from creditors comes about a month after Sienna warned there were substantial doubts about its ability to continue as a going concern, raised the possibility of a bankruptcy filing and said it had hired investment bank Cowen Inc. to explore financial and strategic alternatives.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 30.91
Shares Float (M) 22.74
% Held by Insiders 7.93
% Held by Institutions 50.08
Shares Short (K) 86
Shares Short P. Month (K)

Stock Financials

EPS -2.525
Book Value (p.s.) 0.880
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -26.5
Return on Equity (ttm) -147.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.665
Qtrly Earnings Growth
Operating Cash Flow (M) -52.67
Levered Free Cash Flow (M) -18.67

Stock Valuations

P/E -0.08
P/E Growth Ratio 0.05
P/BV 0.22
P/CF -0.11

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.